Background. Juvenile dermatomyositis associated interstitial lung disease, rarely seen in pediatric age groups, has adverse effects on survival. Anti-melanoma differentiation associated gene 5, one of the identified autoantibodies in juvenile dermatomyositis, preferentially affects the lung tissue and may cause rapidly progressive interstitial lung disease. It is a major cause of mortality in juvenile dermatomyositis. In this case report, we present a pediatric patient diagnosed with juvenile dermatomyositis without anti-melanoma differentiation associated gene 5 antibody positivity
Objective. Patients with anti-Jo-1 antibodies (Abs) and anti–melanoma differentiation-associated pro...
Abstract Background This study aimed to describe the clinical characteristics and analyze the poor p...
Purpose of reviewThis review summarizes the recent developments about anti-MDA5 antibody positive de...
Abstract Background Juvenile dermatomyositis (JDM) is an uncommon inflammatory myopathy predominantl...
A 73-year-old woman who visited our hospital complaining of dry cough for three months was refractor...
Anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody is associated with rapidly prog...
Abstract Background Dermatomyositis with positive anti-melanoma differentiation-associated gene 5 (a...
Objective. Antimelanoma differentiation-associated protein 5 (anti-MDA5) autoantibody has been repor...
AbstractClinically amyopathic dermatomyositis (CADM), a subtype of dermatomyositis (DM), is characte...
Abstract Antimelanoma differentiation‐associated gene 5 antibody (anti‐MDA5 Ab)‐positive dermatomyos...
Abstract Background Clinically amyopathic juvenile dermatomyositis (CAJDM) is a clinical subgroup of...
Dermatomyositis (DM) associated with anti-melanoma differentiation-associated gene 5 (anti-MDA5) ant...
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive clinically amyopathic derma...
Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated w...
We herein report the first case, to our knowledge, of tracheobronchial ulcer with anti-melanoma diff...
Objective. Patients with anti-Jo-1 antibodies (Abs) and anti–melanoma differentiation-associated pro...
Abstract Background This study aimed to describe the clinical characteristics and analyze the poor p...
Purpose of reviewThis review summarizes the recent developments about anti-MDA5 antibody positive de...
Abstract Background Juvenile dermatomyositis (JDM) is an uncommon inflammatory myopathy predominantl...
A 73-year-old woman who visited our hospital complaining of dry cough for three months was refractor...
Anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody is associated with rapidly prog...
Abstract Background Dermatomyositis with positive anti-melanoma differentiation-associated gene 5 (a...
Objective. Antimelanoma differentiation-associated protein 5 (anti-MDA5) autoantibody has been repor...
AbstractClinically amyopathic dermatomyositis (CADM), a subtype of dermatomyositis (DM), is characte...
Abstract Antimelanoma differentiation‐associated gene 5 antibody (anti‐MDA5 Ab)‐positive dermatomyos...
Abstract Background Clinically amyopathic juvenile dermatomyositis (CAJDM) is a clinical subgroup of...
Dermatomyositis (DM) associated with anti-melanoma differentiation-associated gene 5 (anti-MDA5) ant...
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive clinically amyopathic derma...
Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated w...
We herein report the first case, to our knowledge, of tracheobronchial ulcer with anti-melanoma diff...
Objective. Patients with anti-Jo-1 antibodies (Abs) and anti–melanoma differentiation-associated pro...
Abstract Background This study aimed to describe the clinical characteristics and analyze the poor p...
Purpose of reviewThis review summarizes the recent developments about anti-MDA5 antibody positive de...